SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
SEPTEMBER 23, 2002
KOSAN BIOSCIENCES INCORPORATED
(Exact name of registrant specified in its charter)
DELAWARE | 000-31633 | 94-3217016 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employee Identification No.) |
3832 BAY CENTER PLACE HAYWARD, CA 94545
(Address of principal executive offices) (Zip Code)
REGISTRANT’S TELEPHONE, INCLUDING AREA CODE: (510) 732-8400
Item 5. OTHER EVENTS
On September 23, 2002, the Company issued the press release attached to this Form as Exhibit 99.1 and such press release is incorporated herein by reference.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS
99.1 Press Release dated September 23, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
KOSAN BIOSCIENCES INCORPORATED (Registrant) | ||
By | /S/ DANIEL V. SANTI, M.D., PH.D | |
Daniel V. Santi, M.D., Ph.D. Chairman and Chief Executive Officer |
Dated: September 23, 2002
EXHIBIT INDEX
EXHIBIT | ||
99.1 | Press Release dated September 23, 2002. |